2,889
Views
129
CrossRef citations to date
0
Altmetric
Report

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice

, , , , &
Pages 740-752 | Published online: 05 Sep 2012

Figures & data

Figure 1. Size distribution of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations: (A) SEC with UV detection at 280 nm; (B) SEC with MALLS detection and the estimated molar mass of each peak; (C) submicron particles (determined by NTA), (D) micron-sized particles (determined by LO).

Figure 1. Size distribution of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations: (A) SEC with UV detection at 280 nm; (B) SEC with MALLS detection and the estimated molar mass of each peak; (C) submicron particles (determined by NTA), (D) micron-sized particles (determined by LO).

Table 1. AUC percentages from SEC-UV analysis and particles/ml of NTA and LO measurements of unstressed and stressed IgG formulations

Figure 2. Representative microscopy images (20x amplification) of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations after filtration through a 0.22 μm filter, followed by staining with Coomassie brilliant blue. *The filtered volume used for the shaken formulation was 10 times lower than that for the other formulations due to filter blockage.

Figure 2. Representative microscopy images (20x amplification) of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations after filtration through a 0.22 μm filter, followed by staining with Coomassie brilliant blue. *The filtered volume used for the shaken formulation was 10 times lower than that for the other formulations due to filter blockage.

Figure 3. Structural characterization of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations by (A) far-UV CD, (B) near-UV CD and (C) Bis-ANS fluorescence.

Figure 3. Structural characterization of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations by (A) far-UV CD, (B) near-UV CD and (C) Bis-ANS fluorescence.

Figure 4. SDS-PAGE gels of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations stained with Coomassie brilliant blue under (A) non-reducing and (B) reducing conditions. Dot blots of the same formulations detected with (C) monoclonal anti-human κ light chain antibody (D) polyclonal anti-human heavy chain antibody.

Figure 4. SDS-PAGE gels of unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) IgG formulations stained with Coomassie brilliant blue under (A) non-reducing and (B) reducing conditions. Dot blots of the same formulations detected with (C) monoclonal anti-human κ light chain antibody (D) polyclonal anti-human heavy chain antibody.

Table 2. Summary of physicochemical characteristics of unstressed and stressed IgG formulations

Figure 5. ADA titers of the sera of non-transgenic (NTG) and transgenic (TG) mice treated with unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) human IgG formulations. Time points before the first injection (week 0), during the injection period (week 3 and 5) and after the last injection (week 7 to 16) are shown. The titers are from responders only and the error bars represent the standard deviation of the mean values.

Figure 5. ADA titers of the sera of non-transgenic (NTG) and transgenic (TG) mice treated with unstressed (Unst), freeze-thawed (FT), pH-shifted (pH), heated (Heat), shaken (Shake) and metal-catalyzed oxidized (Metal Ox) human IgG formulations. Time points before the first injection (week 0), during the injection period (week 3 and 5) and after the last injection (week 7 to 16) are shown. The titers are from responders only and the error bars represent the standard deviation of the mean values.
Supplemental material

Additional material

Download Zip (45.9 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.